Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ampio Pharmaceuticals Inc AMPE

Healthcare
Ampio Pharmaceuticals, Inc. is a drug discovery and development company. The Company is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.


GREY:AMPE - Post by User

Ampio Pharmaceuticals Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(267)
•••
Post by whytestockson May 28, 2023 7:44am
130 Views
Post# 35467711

Ampio Pharmaceuticals Announces Series D Preferred Stock Div

Ampio Pharmaceuticals Announces Series D Preferred Stock Div
NEWS: $AMPE Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common StockAmpio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common Stock PR Newswire ENGLEWOOD, Colo. , May 26, 2023 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company") today announced that its Board of Direct...AMPE - Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common Stock

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities